SCHEMBL3969641

SCHEMBL3969641

COc1cc(OC)cc(C2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 7/20 0.86
TP53 P04637 7/20 0.86
MAOB P27338 2/20 0.43
TOP2A P11388 1/20 0.41
CBX7 O95931 1/20 0.41
CDYL Q9Y232 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
MAPT P10636 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
PGR P06401 1/20 0.39
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968099 0.92 MDM2 (1.00) MDM2TP53MAOBCBX7CDYL
SCHEMBL3968096 0.92 MDM2 (1.00) MDM2TP53MAOBCBX7CDYL
SCHEMBL3964752 0.89 MDM2 (0.94) MDM2TP53MAOBCBX7CDYL
SCHEMBL3968204 0.86 MDM2 (0.88) MDM2TP53MAOBCBX7CDYL
SCHEMBL3964604 0.84 MDM2 (0.86) MDM2TP53MAOBCBX7CDYL
SCHEMBL3969587 0.84 MDM2 (0.85) MDM2TP53MAOBCBX7CDYL
SCHEMBL3966369 0.84 MDM2 (0.85) MDM2TP53MAOBCBX7CDYL
SCHEMBL3968763 0.83 TP53 (0.84) MDM2TP53MAOBCBX7CDYL
SCHEMBL3962261 0.83 MDM2 (0.70) MDM2TP53MAOBCBX7CDYL
SCHEMBL3973955 0.81 MDM2 (0.80) MDM2TP53CBX7CDYLADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576082-B2 Oxindole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US claimed
JP-2008543917-A 2008-12-04 JP claimed
EP-1896412-A2 OXINDOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-03-12 EP claimed
WO-2006136606-A2 OXINDOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-28 WO claimed
US-20060293319-A1 Oxindole derivatives LUK KIM-CHUN 2006-12-28 US claimed
US-7576082-B2 Oxindole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
US-7576082-B2 Oxindole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
US-7576082-B2 Oxindole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1896412-A2 OXINDOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-03-12 EP disclosed
WO-2006136606-A2 OXINDOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-28 WO disclosed
WO-2006136606-A2 OXINDOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-28 WO disclosed
US-20060293319-A1 Oxindole derivatives LUK KIM-CHUN 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293319-A1 Oxindole derivatives CCNI, OGFR, MKI67 MDM2 759/4885TP53 96/4885MAOB 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.